Glenmark Pharma reports positive results from a Phase 3 trial of GSP 301
Glenmark Pharmaceuticals, a global pharmaceutical company announced positive results for GSP 301, an investigational fixed-dose combination of mometasone furoate (25 mcg) and olopatadine hydrochloride...
Icertis Extends Leadership in Pharmaceutical Market with Update to Clinical Trial Agreement
Icertis, the leading provider of enterprise contract management in the cloud announced an upgrade to the Icertis Clinical Trial Agreement and Budgeting solution designed...
Medigene Revises Collaboration With Mitsui Norin regarding its drug Veregen
Medigene had contracted Mitsui Norin since 2005 for manufacturing and supplying the active pharmaceutical ingredient (API) of Veregen®. Based on new supporting data regarding...
Recipharm partners with Sato to manufacture product for Japanese market
Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and...
BioSig Technologies Announces Strategic Partnership with Mayo Clinic
BioSig Technologies, Inc , a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for...
Jazz Pharmaceuticals enrolls first patient in phase 3 clinical study of JZP-258 to treat adult narcolepsy patients
Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an investigational oxybate product candidate...
Catalyst Pharmaceuticals announces ‘positive’ data from Firdapse trial
Catalyst Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular and neurological diseases announced positive...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...